Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Innospec (NASDAQ:IOSP) Share Price

Press coverage about Innospec (NASDAQ:IOSP) has been trending somewhat positive this week, Accern reports. The research group identifies negative and positive media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Innospec earned a news impact score of 0.22 on Accern’s scale. Accern also assigned news headlines about the specialty chemicals company an impact score of 46.5197223613456 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Innospec (NASDAQ:IOSP) traded down 0.72% during mid-day trading on Thursday, hitting $61.70. 76,219 shares of the stock were exchanged. The company has a market capitalization of $1.49 billion, a PE ratio of 19.64 and a beta of 1.18. The stock has a 50 day moving average price of $60.24 and a 200 day moving average price of $62.15. Innospec has a 1-year low of $54.10 and a 1-year high of $74.75.

Innospec (NASDAQ:IOSP) last issued its quarterly earnings results on Tuesday, August 8th. The specialty chemicals company reported $1.16 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.08 by $0.08. The company had revenue of $326.30 million for the quarter. Innospec had a return on equity of 14.77% and a net margin of 7.22%. On average, equities analysts anticipate that Innospec will post $4.23 earnings per share for the current fiscal year.

IOSP has been the topic of a number of research reports. Zacks Investment Research lowered shares of Innospec from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, July 12th. BidaskClub lowered shares of Innospec from a “sell” rating to a “strong sell” rating in a research note on Thursday, July 27th. ValuEngine lowered shares of Innospec from a “buy” rating to a “hold” rating in a research note on Monday, August 7th. Finally, Monness Crespi & Hardt raised shares of Innospec from a “neutral” rating to a “buy” rating and set a $65.00 price target on the stock in a research note on Tuesday, August 22nd.

TRADEMARK VIOLATION NOTICE: “Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Innospec (NASDAQ:IOSP) Share Price” was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this story on another site, it was copied illegally and reposted in violation of international copyright and trademark laws. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2017/10/26/somewhat-favorable-media-coverage-somewhat-unlikely-to-impact-innospec-iosp-stock-price.html.

Innospec Company Profile

Innospec Inc is a specialty chemicals company engaged in developing, manufacturing, blending, marketing and supplying of specialty chemicals for use as fuel additives and ingredients for personal care, home care, agrochemical, mining and other applications and oilfield chemicals. The Company operates through four business segments: Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives.

Insider Buying and Selling by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply